References
- U.S. Renal Data System, In USRDS 1997 Annual Data Report; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, April 1999.
- Foley, R N.; Parfrey, P S.; Sarnak, M J. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am. J. Kidney Dis. 1998, 32 (Suppl. 3), 112–119.
- Koch, K M. Dialysis-related amyloidosis. Kidney Int. 1992, 41, 1416–1429. [PUBMED], [INFOTRIEVE]
- Von Albertini, B.; Miller, J H.; Gardener, P W.; Shinaberger, J H. Performance characteristics of the hemoflow F60 in high-flux hemofiltration. Contrib. Nephrol. 1985, 46, 69–70.
- Van Ypserele, C.; Jadoul, M.; Malghem, J.; Maldague, B.; Jamart, J. Effect of dialysis membranes and patients ages on signs of dialysis related amyloidosis. Kidney Int. 1991, 39, 1012–1019.
- Shimizu, S.; Yasui, C.; Yasukawa, K.; Nakamura, H.; Shimizu, H.; Tsuchiya, K. Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity? Br. J. Dermatol. 2003, 149 (2), 400–404. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Daugirdas, J T.; Depner, T A.; Gotch, F A.; Greene, T.; Keshaviah, P.; Levin, N W.; Schulman, G. Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int. 1997, 52 (5), 1395–1405. [PUBMED], [INFOTRIEVE]
- Locatelli, F.; Andrulli, S.; Pecchini, F. Effect of high-flux dialysis on the anemia of hemodialysis patients. Nephrol. Dial. Transplant. 2000, 15, 1399–1409. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kim, S T.; Yamamoto, C.; Taoka, M.; Takasugi, M. Programmed filtration, a new method for removing large molecules and regulating albumin leakage during hemodiafiltration treatment. Am. J. Kidney Dis. 2001, 38 (4 Suppl. 1), S220–S223. [PUBMED], [INFOTRIEVE]
- Moe, S M.; Drueke, T B. Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am. J. Nephrol. 2003, 23 (6), 369–379. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brancaccio, D.; Cozzolino, M.; Gorio, A.; Di Giulio, A M.; Gallieni, M. Bone disease in uremic patients: advances in PTH suppression. J. Nephrol. 2002, 15 (Suppl. 6), S86–S93. [PUBMED], [INFOTRIEVE]
- Koda, Y.; , et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int. 1997, 52, 1096–1101. [PUBMED], [INFOTRIEVE]
- Küche, C.; , et al. High-flux hemodialysis postpones clinical manifestations of dialysis related amyloidosis. Am. J. Nephrol. 1996, 16, 484–488. [CSA]
- Schiffl, H.; Fischer, R.; Lang, S M.; Mangel, E. Clinical manifestations of AB-amyloidosis: effect of biocompatibility and flux. Nephrol. Dial. Transplant. 2000, 15, 840–845. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]